Bioorganic & Medicinal Chemistry Letters 2005-12-01

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

Katrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, Holger Kühne, David W Banner, Hans-Joachim Böhm, Martin Stahl, Jean Ackermann, Leo Alig, Lutz Weber, Hans Peter Wessel, Markus A Riederer, Thomas B Tschopp, Thierry Lavé

Index: Bioorg. Med. Chem. Lett. 15(23) , 5344-52, (2005)

Full Text: HTML

Abstract

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.

Related Compounds

Related Articles:

Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum.

2013-04-01

[Bioorg. Med. Chem. Lett. 16 , 1138-41, (2006)]

Two plate-based colorimetric assays for screening α-amino acid ester hydrolase with high synthesis/hydrolysis ratio.

2012-07-15

[Enzyme Microb. Technol. 51(2) , 107-12, (2012)]

Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

2009-09-01

[J. Pharmacol. Exp. Ther. 330(3) , 783-91, (2009)]

Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

2010-01-01

[Bioorg. Med. Chem. Lett. 20(1) , 87-91, (2010)]

Isolation and characterization of a benzoylformate decarboxylase and a NAD+/NADP+-dependent benzaldehyde dehydrogenase involved in D-phenylglycine metabolism in Pseudomonas stutzeri ST-201.

2007-11-01

[Biochim. Biophys. Acta 1770(11) , 1585-92, (2007)]

More Articles...